RCE 0.97% 52.0¢ recce pharmaceuticals ltd

Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 602 Posts.
    lightbulb Created with Sketch. 361
    Bpharma, you must get sick of being wrong.
    What is even a "lease photo"? Why would you need to take a photo to report on trial participant numbers? Nothing you say makes sense.

    Here is the actual trial info:
    https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381443

    Six participants were enrolled and commenced trial medication.
    Four participants received topical dosing to wounds as per protocol.
    One participant stopped treatment early.
    One participant switched to conventional antibiotic therapy.

 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.